223 related articles for article (PubMed ID: 28587113)
1. The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.
Hu CT; Wu JR; Cheng CC; Wu WS
Cancers (Basel); 2017 May; 9(6):. PubMed ID: 28587113
[TBL] [Abstract][Full Text] [Related]
2. PKCε-mediated c-Met endosomal processing directs fluctuant c-Met-JNK-paxillin signaling for tumor progression of HepG2.
Hu CT; Cheng CC; Wu JR; Pan SM; Wu WS
Cell Signal; 2015 Jul; 27(7):1544-55. PubMed ID: 25778903
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma.
Wu JR; You RI; Hu CT; Cheng CC; Rudy R; Wu WS
Oncogenesis; 2019 Aug; 8(8):40. PubMed ID: 31387985
[TBL] [Abstract][Full Text] [Related]
5. Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.
Wu JR; Hu CT; You RI; Ma PL; Pan SM; Lee MC; Wu WS
PLoS One; 2015; 10(1):e0114495. PubMed ID: 25607934
[TBL] [Abstract][Full Text] [Related]
6. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma.
Wang H; Rao B; Lou J; Li J; Liu Z; Li A; Cui G; Ren Z; Yu Z
Front Cell Dev Biol; 2020; 8():55. PubMed ID: 32117981
[TBL] [Abstract][Full Text] [Related]
7. Preclinical trial of targeting the Hic-5-mediated pathway to prevent the progression of hepatocellular carcinoma.
Wu WS; Cheng CC; Lee YH; Wei JL; Chen RF; Lin CF; You RI; Chen YC; Shih HM; Hu CT; Chang HH; Lee MC; Chen YC
Am J Cancer Res; 2023; 13(10):4903-4917. PubMed ID: 37970347
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
[TBL] [Abstract][Full Text] [Related]
9. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
Korhan P; Erdal E; Atabey N
Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462
[TBL] [Abstract][Full Text] [Related]
10. c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
Granito A; Guidetti E; Gramantieri L
J Hepatocell Carcinoma; 2015; 2():29-38. PubMed ID: 27508192
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase.
Nakanishi K; Fujimoto J; Ueki T; Kishimoto K; Hashimoto-Tamaoki T; Furuyama J; Itoh T; Sasaki Y; Okamoto E
Clin Exp Metastasis; 1999; 17(6):507-14. PubMed ID: 10763917
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of heat shock protein 60 and protein disulfide isomerase activates ERK and migration of human hepatocellular carcinoma HepG2.
Lin CY; Hu CT; Cheng CC; Lee MC; Pan SM; Lin TY; Wu WS
Oncotarget; 2016 Mar; 7(10):11067-82. PubMed ID: 26840563
[TBL] [Abstract][Full Text] [Related]
13. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
García-Vilas JA; Medina MÁ
World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
[TBL] [Abstract][Full Text] [Related]
14. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy.
Xie Q; Su Y; Dykema K; Johnson J; Koeman J; De Giorgi V; Huang A; Schlegel R; Essenburg C; Kang L; Iwaya K; Seki S; Khoo SK; Zhang B; Buonaguro F; Marincola FM; Furge K; Vande Woude GF; Shinomiya N
Genes Cancer; 2013 Jul; 4(7-8):247-60. PubMed ID: 24167653
[TBL] [Abstract][Full Text] [Related]
16. The role of hydrogen peroxide-inducible clone-5 in tumor progression.
Wu WS
Ci Ji Yi Xue Za Zhi; 2020; 32(1):1-4. PubMed ID: 32110512
[TBL] [Abstract][Full Text] [Related]
17. Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma.
Gao J; Inagaki Y; Song P; Qu X; Kokudo N; Tang W
Pharmacol Res; 2012 Jan; 65(1):23-30. PubMed ID: 22138044
[TBL] [Abstract][Full Text] [Related]
18. Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.
Gao W; Kim H; Ho M
PLoS One; 2015; 10(9):e0137664. PubMed ID: 26332121
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway.
Gao F; Deng G; Liu W; Zhou K; Li M
Oncol Rep; 2017 Feb; 37(2):1203-1211. PubMed ID: 28075467
[TBL] [Abstract][Full Text] [Related]
20. Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinoma.
Dang H; Steinway SN; Ding W; Rountree CB
BMC Cancer; 2015 Mar; 15():161. PubMed ID: 25886575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]